Download PDF
Semin Neurol 2021; 41(06): 686-698
DOI: 10.1055/s-0041-1726354
Review Article

A Neurologist's Practical Approach to Cognitive Impairment

Philip W. Tipton 
1   Department of Neurology, Mayo Clinic, Jacksonville, Florida
,
Gregory S. Day 
1   Department of Neurology, Mayo Clinic, Jacksonville, Florida
,
Neill Graff-Radford
1   Department of Neurology, Mayo Clinic, Jacksonville, Florida
› Author Affiliations Funding This study was funded, in part, by the David Eisenberg Professorship from Mayo Foundation for N.G-R. and National Institutes of Health K23AG064029 for G.S.D.
› Further Information
    Permissions and Reprints

Abstract

The global prevalence of dementia is expected to triple by the year 2050. This impending health care crisis has led to new heights of public awareness and general concern regarding cognitive impairment. Subsequently, clinicians are seeing more and more people presenting with cognitive concerns. It is important that clinicians meet these concerns with a strategy promoting accurate diagnoses. We have diagramed and described a practical approach to cognitive impairment. Through an algorithmic approach, we determine the presence and severity of cognitive impairment, systematically evaluate domains of function, and use this information to determine the next steps in evaluation. We also discuss how to proceed when cognitive impairment is associated with motor abnormalities or rapid progression.

Keywords

cognitive impairment - dementia - rapidly progressive dementia - clinical assessment

Authors' Contributions

P.W.T.: Manuscript writing; G.S.D.: Manuscript writing and editing; N.G-R.: Manuscript writing and editing.




Publication History

Article published online:
26 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 McKhann GM, Knopman DS, Chertkow H. et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7 (03) 263-269
    CrossrefPubMedSearch in Google Scholar
  • 2 Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. World Alzheimer Report 2015 The global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer's Disease International 2015. Accessed February 25, 2020 at: https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf
    PubMed
  • 3 Alzheimer's Association. 2019 Alzheimer's disease facts and figures. Alzheimers Dement 2019; 15 (03) 321-387
    CrossrefPubMedSearch in Google Scholar
  • 4 Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol 2012; 71 (04) 266-273
    CrossrefPubMedSearch in Google Scholar
  • 5 Ferman TJ, Aoki N, Crook JE. et al. The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies. Alzheimers Dement 2018; 14 (03) 330-339
    CrossrefPubMedSearch in Google Scholar
  • 6 Irwin DJ, Grossman M, Weintraub D. et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 2017; 16 (01) 55-65
    CrossrefPubMedSearch in Google Scholar
  • 7 Walker L, McAleese KE, Thomas AJ. et al. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 2015; 129 (05) 729-748
    CrossrefPubMedSearch in Google Scholar
  • 8 Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathol 2003; 105 (01) 14-17
    CrossrefPubMedSearch in Google Scholar
  • 9 Custodio N, Montesinos R, Lira D, Herrera-Pérez E, Bardales Y, Valeriano-Lorenzo L. Mixed dementia: a review of the evidence. Dement Neuropsychol 2017; 11 (04) 364-370
    CrossrefPubMedSearch in Google Scholar
  • 10 Jansen WJ, Wilson RS, Visser PJ. et al. Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging 2018; 61: 138-145
    CrossrefPubMedSearch in Google Scholar
  • 11 Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12 (03) 189-198
    CrossrefPubMedSearch in Google Scholar
  • 12 Nasreddine ZS, Phillips NA, Bédirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (04) 695-699
    CrossrefPubMedSearch in Google Scholar
  • 13 Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results. Mayo Clin Proc 1987; 62 (04) 281-288
    CrossrefPubMedSearch in Google Scholar
  • 14 Townley RA, Syrjanen JA, Botha H. et al. Comparison of the short test of mental status and the Montreal Cognitive Assessment across the cognitive spectrum. Mayo Clin Proc 2019; 94 (08) 1516-1523
    CrossrefPubMedSearch in Google Scholar
  • 15 Petersen RC, Lopez O, Armstrong MJ. et al. Practice guideline update summary: Mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018; 90 (03) 126-135
    CrossrefPubMedSearch in Google Scholar
  • 16 Bartsch T, Butler C. Transient amnesic syndromes. Nat Rev Neurol 2013; 9 (02) 86-97
    CrossrefPubMedSearch in Google Scholar
  • 17 O'Keeffe ST, Tormey WP, Glasgow R, Lavan JN. Thiamine deficiency in hospitalized elderly patients. Gerontology 1994; 40 (01) 18-24
    CrossrefPubMedSearch in Google Scholar
  • 18 Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 1971; 7: 1-206
    PubMedSearch in Google Scholar
  • 19 Wernicke C. Die akute haemorrhagische polioencephalitis superior Lehrbuch derGehirnkrankheiten fur aerzte und studirende, Bd II, Fisher Verlag, Kassel; 1881(02):229–422
    PubMed
  • 20 Cravioto H, Korein J, Silberman J. Wernicke's encephalopathy. A clinical and pathological study of 28 autopsied cases. Arch Neurol 1961; 4: 510-519
    CrossrefPubMedSearch in Google Scholar
  • 21 Nishimoto A, Usery J, Winton JC, Twilla J. High-dose parenteral thiamine in treatment of Wernicke's encephalopathy: case series and review of the literature. In Vivo 2017; 31 (01) 121-124
    CrossrefPubMedSearch in Google Scholar
  • 22 Day GS, Ladak S, Curley K. et al. Thiamine prescribing practices within university-affiliated hospitals: a multicenter retrospective review. J Hosp Med 2015; 10 (04) 246-253
    CrossrefPubMedSearch in Google Scholar
  • 23 Day GS, del Campo CM. Wernicke encephalopathy: a medical emergency. CMAJ 2014; 186 (08) E295
    CrossrefPubMedSearch in Google Scholar
  • 24 Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol 2010; 17 (12) 1408-1418
    CrossrefPubMedSearch in Google Scholar
  • 25 Thomson AD, Cook CCH, Touquet R, Henry JA. Royal College of Physicians, London. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and emergency department. Alcohol Alcohol 2002; 37 (06) 513-521
    CrossrefPubMedSearch in Google Scholar
  • 26 Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 2011; 10 (09) 785-796
    CrossrefPubMedSearch in Google Scholar
  • 27 Nelson PT, Dickson DW, Trojanowski JQ. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 2019; 142 (06) 1503-1527
    CrossrefPubMedSearch in Google Scholar
  • 28 McKeith IG, Boeve BF, Dickson DW. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017; 89 (01) 88-100
    CrossrefPubMedSearch in Google Scholar
  • 29 Kipps CM, Hodges JR. Cognitive assessment for clinicians. J Neurol Neurosurg Psychiatry 2005; 76 (Suppl. 01) i22-i30
    CrossrefPubMedSearch in Google Scholar
  • 30 Shaw LM, Arias J, Blennow K. et al. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease. Alzheimers Dement 2018; 14 (11) 1505-1521
    CrossrefPubMedSearch in Google Scholar
  • 31 Gorno-Tempini ML, Hillis AE, Weintraub S. et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76 (11) 1006-1014
    CrossrefPubMedSearch in Google Scholar
  • 32 Gorno-Tempini ML, Brambati SM, Ginex V. et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008; 71 (16) 1227-1234
    CrossrefPubMedSearch in Google Scholar
  • 33 Renner JA, Burns JM, Hou CE, McKeel Jr DW, Storandt M, Morris JC. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 2004; 63 (07) 1175-1180
    CrossrefPubMedSearch in Google Scholar
  • 34 Crutch SJ, Schott JM, Rabinovici GD. et al; Alzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area. Consensus classification of posterior cortical atrophy. Alzheimers Dement 2017; 13 (08) 870-884
    CrossrefPubMedSearch in Google Scholar
  • 35 Josephs KA, Whitwell JL, Knopman DS. et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology 2009; 73 (18) 1443-1450
    CrossrefPubMedSearch in Google Scholar
  • 36 Mori E, Shimomura T, Fujimori M. et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000; 57 (04) 489-493
    CrossrefPubMedSearch in Google Scholar
  • 37 Hamilton JM, Landy KM, Salmon DP, Hansen LA, Masliah E, Galasko D. Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies. Am J Geriatr Psychiatry 2012; 20 (09) 773-781
    CrossrefPubMedSearch in Google Scholar
  • 38 Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M. et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol 1999; 56 (01) 55-61
    CrossrefPubMedSearch in Google Scholar
  • 39 Hopf HC, Althaus HH, Sabuncu S. “Typ Heidenhain” der subakuten spongiösen Encephalopathie (SSE) Creutzfeldt-Jakob. Z Neurol 1974; 206 (02) 149-156
    PubMedSearch in Google Scholar
  • 40 Rascovsky K, Hodges JR, Knopman D. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134 (Pt 9): 2456-2477
    CrossrefPubMedSearch in Google Scholar
  • 41 Radhakrishnan R, Ganesh S, Meltzer HY. et al. Schizophrenia. In: Ebert MH, Leckman JF, Petrakis IL. eds. Current Diagnosis & Treatment: Psychiatry. 3rd ed.. McGraw-Hill Education; 2019: 207-235
    Search in Google Scholar
  • 42 Graus F, Titulaer MJ, Balu R. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15 (04) 391-404
    CrossrefPubMedSearch in Google Scholar
  • 43 Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA 2020; 323 (06) 548-560
    CrossrefPubMedSearch in Google Scholar
  • 44 Postuma RB, Adler CH, Dugger BN. et al. REM sleep behavior disorder and neuropathology in Parkinson's disease. Mov Disord 2015; 30 (10) 1413-1417
    CrossrefPubMedSearch in Google Scholar
  • 45 Postuma RB, Berg D. Prodromal Parkinson's disease: the decade past, the decade to come. Mov Disord 2019; 34 (05) 665-675
    CrossrefPubMedSearch in Google Scholar
  • 46 Stanković I, Petrović I, Pekmezović T. et al. Longitudinal assessment of autonomic dysfunction in early Parkinson's disease. Parkinsonism Relat Disord 2019; 66: 74-79
    CrossrefPubMedSearch in Google Scholar
  • 47 Doty RL. Olfaction in Parkinson's disease and related disorders. Neurobiol Dis 2012; 46 (03) 527-552
    CrossrefPubMedSearch in Google Scholar
  • 48 van Gerpen JA, Al-Shaikh RH, Tipton PW. et al. Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. Neurology 2019; 93 (14) e1339-e1347
    CrossrefPubMedSearch in Google Scholar
  • 49 Ferman TJ, Smith GE, Kantarci K. et al. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 2013; 81 (23) 2032-2038
    CrossrefPubMedSearch in Google Scholar
  • 50 Koga S, Parks A, Uitti RJ. et al. Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord 2017; 32 (03) 405-413
    CrossrefPubMedSearch in Google Scholar
  • 51 Kompoliti K, Goetz CG, Boeve BF. et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998; 55 (07) 957-961
    CrossrefPubMedSearch in Google Scholar
  • 52 Armstrong MJ, Litvan I, Lang AE. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80 (05) 496-503
    CrossrefPubMedSearch in Google Scholar
  • 53 Boeve BF, Maraganore DM, Parisi JE. et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53 (04) 795-800
    CrossrefPubMedSearch in Google Scholar
  • 54 Hu WT, Rippon GW, Boeve BF. et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009; 24 (09) 1375-1379
    CrossrefPubMedSearch in Google Scholar
  • 55 Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life?. Mov Disord 2009; 24 (11) 1593-1599
    CrossrefPubMedSearch in Google Scholar
  • 56 Whitwell JL, Jack Jr CR, Boeve BF. et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 2010; 75 (21) 1879-1887
    CrossrefPubMedSearch in Google Scholar
  • 57 Jankovic J, Friedman DI, Pirozzolo FJ, McCrary JA. Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol 1990; 53: 293-304
    PubMedSearch in Google Scholar
  • 58 McFarland NR. Diagnostic approach to atypical Parkinsonian syndromes. Continuum (Minneap Minn) 2016; 22 (4 Movement Disorders): 1117-1142
    CrossrefPubMedSearch in Google Scholar
  • 59 Höglinger GU, Respondek G, Stamelou M. et al; Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 2017; 32 (06) 853-864
    CrossrefPubMedSearch in Google Scholar
  • 60 Massey LA, Jäger HR, Paviour DC. et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013; 80 (20) 1856-1861
    CrossrefPubMedSearch in Google Scholar
  • 61 Gilman S, Wenning GK, Low PA. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71 (09) 670-676
    CrossrefPubMedSearch in Google Scholar
  • 62 Rossi M, Perez-Lloret S, Doldan L. et al. Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur J Neurol 2014; 21 (04) 607-615
    CrossrefPubMedSearch in Google Scholar
  • 63 Graff-Radford NR, Jones DT. Normal pressure hydrocephalus. Continuum (Minneap Minn) 2019; 25 (01) 165-186
    CrossrefPubMedSearch in Google Scholar
  • 64 Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss D. Practice guideline: idiopathic normal pressure hydrocephalus: response to shunting and predictors of response: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2015; 85 (23) 2063-2071
    CrossrefPubMedSearch in Google Scholar
  • 65 Statland JM, Barohn RJ, McVey AL, Katz J, Dimachkie MM. Patterns of weakness, classification of motor neuron disease & clinical diagnosis of sporadic ALS. Neurol Clin 2015; 33 (04) 735-748
    CrossrefPubMedSearch in Google Scholar
  • 66 Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002; 59 (07) 1077-1079
    CrossrefPubMedSearch in Google Scholar
  • 67 Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005; 65 (04) 586-590
    CrossrefPubMedSearch in Google Scholar
  • 68 Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology 2003; 60 (07) 1094-1097
    CrossrefPubMedSearch in Google Scholar
  • 69 Garg RK, Malhotra HS, Kumar N. Approach to a case of myeloneuropathy. Ann Indian Acad Neurol 2016; 19 (02) 183-187
    CrossrefPubMedSearch in Google Scholar
  • 70 Kumar N. Metabolic and toxic myelopathies. Semin Neurol 2012; 32 (02) 123-136
    Thieme ConnectPubMedSearch in Google Scholar
  • 71 Blackstone C. Hereditary spastic paraplegia. Handb Clin Neurol 2018; 148: 633-652
    CrossrefPubMedSearch in Google Scholar
  • 72 Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42 (01) 85-94
    CrossrefPubMedSearch in Google Scholar
  • 73 Ishii K, Sakamoto S, Sasaki M. et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998; 39 (11) 1875-1878
    PubMedSearch in Google Scholar
  • 74 Botha H, Whitwell JL, Madhaven A, Senjem ML, Lowe V, Josephs KA. The pimple sign of progressive supranuclear palsy syndrome. Parkinsonism Relat Disord 2014; 20 (02) 180-185
    CrossrefPubMedSearch in Google Scholar
  • 75 Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol 2008; 64 (01) 97-108
    CrossrefPubMedSearch in Google Scholar
  • 76 Geschwind MD. Rapidly progressive dementia. Continuum (Minneap Minn) 2016; 22 (2 Dementia): 510-537
    PubMedSearch in Google Scholar
  • 77 Josephs KA, Ahlskog JE, Parisi JE. et al. Rapidly progressive neurodegenerative dementias. Arch Neurol 2009; 66 (02) 201-207
    CrossrefPubMedSearch in Google Scholar
  • 78 Poser S, Mollenhauer B, Kraubeta A. et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122 (Pt 12): 2345-2351
    CrossrefPubMedSearch in Google Scholar
  • 79 Sala I, Marquié M, Sánchez-Saudinós MB. et al. Rapidly progressive dementia: experience in a tertiary care medical center. Alzheimer Dis Assoc Disord 2012; 26 (03) 267-271
    CrossrefPubMedSearch in Google Scholar
  • 80 Chitravas N, Jung RS, Kofskey DM. et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 2011; 70 (03) 437-444
    CrossrefPubMedSearch in Google Scholar
  • 81 Day GS, Musiek ES, Morris JC. Rapidly progressive dementia in the outpatient clinic: more than prions. Alzheimer Dis Assoc Disord 2018; 32 (04) 291-297
    CrossrefPubMedSearch in Google Scholar
  • 82 Kelley BJ, Boeve BF, Josephs KA. Young-onset dementia: demographic and etiologic characteristics of 235 patients. Arch Neurol 2008; 65 (11) 1502-1508
    CrossrefPubMedSearch in Google Scholar
  • 83 Woodruff BK. Evaluation of rapidly progressive dementia. Semin Neurol 2007; 27 (04) 363-375
    Thieme ConnectPubMedSearch in Google Scholar
  • 84 Day GS, Tang-Wai DF. When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia. Neurodegener Dis Manag 2014; 4 (01) 41-56
    CrossrefPubMedSearch in Google Scholar
  • 85 Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin JJ, Cras P. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol 2004; 251 (03) 298-304
    CrossrefPubMedSearch in Google Scholar
  • 86 Long JM, Day GS. Autoimmune dementia. Semin Neurol 2018; 38 (03) 303-315
    Thieme ConnectPubMedSearch in Google Scholar
  • 87 Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008; 70 (20) 1883-1890
    CrossrefPubMedSearch in Google Scholar
  • 88 Sawlani K, Katirji B. Peripheral nerve hyperexcitability syndromes. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1437-1450
    PubMedSearch in Google Scholar
  • 89 Tracy JA, Dyck PJ. Porphyria and its neurologic manifestations. Handb Clin Neurol 2014; 120: 839-849
    CrossrefPubMedSearch in Google Scholar
  • 90 Wilson MR, Sample HA, Zorn KC. et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med 2019; 380 (24) 2327-2340
    CrossrefPubMedSearch in Google Scholar
  • 91 Kleffner I, Dörr J, Ringelstein M. et al; European Susac Consortium (EuSaC). Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry 2016; 87 (12) 1287-1295
    CrossrefPubMedSearch in Google Scholar
  • 92 Stern BJ, Royal III W, Gelfand JM. et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol 2018; 75 (12) 1546-1553
    CrossrefPubMedSearch in Google Scholar
  • 93 Gelfand JM, Genrich G, Green AJ, Tihan T, Cree BA. Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge. JAMA Neurol 2015; 72 (01) 66-72
    CrossrefPubMedSearch in Google Scholar
  • 94 Schott JM, Reiniger L, Thom M. et al. Brain biopsy in dementia: clinical indications and diagnostic approach. Acta Neuropathol 2010; 120 (03) 327-341
    CrossrefPubMedSearch in Google Scholar
  • 95 Josephson SA, Papanastassiou AM, Berger MS. et al. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg 2007; 106 (01) 72-75
    CrossrefPubMedSearch in Google Scholar
  • 96 Warren JD, Schott JM, Fox NC. et al. Brain biopsy in dementia. Brain 2005; 128 (Pt 9): 2016-2025
    CrossrefPubMedSearch in Google Scholar